Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CleanSpace HoldingsASX:CSX -4.71%38 3-Year FCF Growth Rate is 70.40% as of Jun. 2026, which is at its 10-year median of 70.40. GuruFocus rates ASX:CSX with a GF Score™ of 38/100 and a GF Value™ of A$0.52 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 585 Medical Devices & Instruments companies, CleanSpace Holdings ranks better than 90.26% on this metric.
During the past 12 months, CleanSpace Holdings's average Free Cash Flow per Share Growth Rate was -130.80% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 70.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
During the past 7 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of CleanSpace Holdings was 70.40% per year. The lowest was 70.40% per year. And the median was 70.40% per year.
Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.
CleanSpace Holdings 3-Year FCF Growth Rate Related Terms
ASX:CSX vs ABT, SYK, MDT: 3-Year FCF Growth Rate Comparison
For the Medical Devices subindustry, CleanSpace Holdings's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CleanSpace Holdings 3-Year FCF Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CleanSpace Holdings's 3-Year FCF Growth Rate distribution charts can be found below:
* The bar in red indicates where CleanSpace Holdings's 3-Year FCF Growth Rate falls into.
This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
What does a 3-Year FCF Growth Rate of 70.40% mean?
CleanSpace Holdings (ASX:CSX) has a 3-Year FCF Growth Rate of 70.40% as of Jun. 2026. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for CleanSpace Holdings and its competitors. This is near median its historical median of 70.40. Over the past decade, CleanSpace Holdings' 3-Year FCF Growth Rate has ranged from 70.40 to 70.40. According to the industry distribution chart, CleanSpace Holdings ranks #57 out of 585 companies in the Medical Devices & Instruments industry, placing it in the top 9.7%.
Is CleanSpace Holdings' 3-Year FCF Growth Rate too high?
CleanSpace Holdings' current 3-Year FCF Growth Rate of 70.40% is near median its 10-year median of 70.40. Over the past 10 years, this metric has ranged from a low of 70.40 to a high of 70.40. The Medical Devices & Instruments industry median 3-Year FCF Growth Rate is 18.00. CleanSpace Holdings' value of 70.40% is 291.1% above this industry median. Based on the distribution chart, CleanSpace Holdings ranks #57 out of 585 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, CleanSpace Holdings has a GF Score™ of 38/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CleanSpace Holdings' 3-Year FCF Growth Rate compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, CleanSpace Holdings ranks #57 out of 585 companies for 3-Year FCF Growth Rate. This places CleanSpace Holdings in the top 10% of its industry — outperforming the majority of peers. The industry median 3-Year FCF Growth Rate is 18.00. CleanSpace Holdings' value of 70.40% is 291.1% above this benchmark. Historically, CleanSpace Holdings' own 3-Year FCF Growth Rate has ranged from 70.40 to 70.40 over the past decade. While the company's 10-year median is 70.40 vs. the industry median of 18.00, CleanSpace Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year FCF Growth Rate for a Medical Devices & Instruments company?
The median 3-Year FCF Growth Rate among Medical Devices & Instruments companies is 18.00, based on 585 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year FCF Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year FCF Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CleanSpace Holdings's current 3-Year FCF Growth Rate of 70.40% is 291.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year FCF Growth Rate mean?
A high 3-Year FCF Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for CleanSpace Holdings and its competitors. For the Medical Devices & Instruments industry, the median 3-Year FCF Growth Rate is 18.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CleanSpace Holdings's current 3-Year FCF Growth Rate is 70.40%, which is near median its own 10-year median of 70.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CleanSpace Holdings stock overvalued right now?
Based on GuruFocus' analysis, CleanSpace Holdings (ASX:CSX) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.52, compared to a current price of A$0.41 — trading 22.1% below its estimated fair value. The current 3-Year FCF Growth Rate is 70.40%, which is near median its 10-year median of 70.40 and 291.1% above the Medical Devices & Instruments industry median of 18.00. CleanSpace Holdings' overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year FCF Growth Rate calculated?
3-Year FCF Growth Rate is calculated from a company's financial statements. For CleanSpace Holdings (ASX:CSX), the current 3-Year FCF Growth Rate is 70.40% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CleanSpace Holdings (ASX:CSX) Overvalued in 2026?
Based on GuruFocus' analysis, CleanSpace Holdings stock appears to be undervalued.
The current stock price of A$0.41 is trading 22.1% below its estimated GF Value™ of A$0.52.
GuruFocus considers CleanSpace Holdings to be Modestly Undervalued.
Key valuation signals for ASX:CSX:
3-Year FCF Growth Rate: 70.40% (near median its 10-year median of 70.40)
GF Value™: A$0.52 vs. price of A$0.41 (22.1% below fair value)
Industry Position: 291.1% above the Medical Devices & Instruments median (#57 of 585)
No single metric tells the full story. See the ASX:CSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CleanSpace Holdings Ltd manufactures and sells respirators and related products and services. Its products include Compare, CleanSpace HALO, CleanSpace ULTRA, Masks, Filters, and Compatible Products. The company's operating segment is based on regions that include, Europe, Asia, and North America, and the majority of its revenue is generated from Europe.
38GF Score
Get the complete analysis for ASX:CSX
3-Year FCF Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CSX has been successfully added to your 
